Cargando…
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice
INTRODUCTION AND HYPOTHESIS: In randomized clinical trials onabotulinumtoxinA was demonstrated to be an effective and well-tolerated treatment for overactive bladder (OAB) with urinary incontinence (UI). However, data reporting onabotulinumtoxinA use in everyday clinical practice are limited. Here,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788019/ https://www.ncbi.nlm.nih.gov/pubmed/32719964 http://dx.doi.org/10.1007/s00192-020-04423-0 |